Original Article

Measuring the impact of an educational intervention in rheumatoid arthritis: An open-label, randomized trial

Laëtitia Michou, Anne-Sophie Julien, Holly O. Witteman, Jean Légaré, Lucie Ratelle, Alexandra Godbout, Johanne Tardif, Suzanne Côté, Geneviève Boily, Rebecca Lui, Alena Ikic, Judith Trudeau, Jean-Luc Tremblay, Isabelle Fortin, Louis Bessette, Anne-Laure Chetaille, Paul R Fortin

DOI: 10.46497/ArchRheumatol.2022.8965
168 777

Coronaphobia in patients with fibromyalgia

Sevinç Külekçioğlu, Merve Akyüz, Özenç İnan, Alp Çetin

DOI: 10.46497/ArchRheumatol.2022.8664
164 628

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252
173 747

Is COVID-19 multisystem inflammatory syndrome a new variant of Kawasaki Disease?

Khawla Abu Hammour, Rana Abu Farha, Qusai Manaseer, Tasnim Dawoud, Walid Abu Hammour

DOI: 10.46497/ArchRheumatol.2022.9086
192 794

Serum lysyl oxidase concentration increases in long-standing systemic sclerosis: Can lysyl oxidase change over time?

Mohammad Hassan Jokar, Simin Jafaripour, Nafiseh Abdollahi, Maryam Nazemipour, Maliheh Moradzadeh, Mohammad Ali Mansournia

DOI: 10.46497/ArchRheumatol.2022.8977
141 831

Review

Vasculitis induced by biological agents used in rheumatology practice: A systematic review

Camila da Silva Cendon Duran, Adriane Souza da Paz, Mittermayer Barreto Santiago

DOI: 10.46497/ArchRheumatol.2022.9049
191 560

Letter to the Editor

Fibrillarin antibodies in systemic sclerosis

Adrian Lee

DOI: 10.46497/ArchRheumatol.2022.9038
775 573